Hepatitis B Virus Infection in Liver Cirrhosis and Hepatocellular Carcinoma in Jakarta Indonesia

Overview

Journal Gastroenterol Jpn

Specialty Gastroenterology

Date 1989 Aug 1

PMID 2550307

Citations 4

Authors

H A Sulaiman

Affiliations

Soon will be listed here.

Abstract

The relationship between hepatitis B virus (HBV) infection and 144 cases with liver cirrhosis (LC) and 82 cases with hepatocellular carcinoma (HCC), admitted to the Department of Internal Medicine, Dr. Cipto Mangunkusmo Hospital in Jakarta, was investigated within the period from January 1 until December 31, 1984. The prevalence of HBsAg in 144 cases with LC was 41.1%, anti-HBs 33.3% and anti-HBc alone 16.0%. In only 9.0% no markers were found. The prevalence of HBeAg in 60 cases HBsAg positive LC was 35.0%, anti-HBe was 41.7% and in 23.3% both markers were negative. Among 82 cases with HCC, the prevalence of HBsAg was 47.6%, anti-HBs was 25.6% and anti-HBc alone was 15.9%. The prevalence of HBeAg in 39 cases with HCC was 25.6%, anti-HBe was 51.3% and in 23.1% both markers were negative. Age distribution between HBsAg positive and negative in LC was observed significant difference (P less than 0.05). Mean age of HBsAg positive group in LC was 5 years younger than that of the HBsAg negative group.

Citing Articles

Prevalence of Hepatocellular Carcinoma in Hepatitis B Population within Southeast Asia: A Systematic Review and Meta-Analysis of 39,050 Participants.

Rabaan A, Bello K, Irekeola A, Al Kaabi N, A Halwani M, Yousuf A Pathogens. 2023; 12(10).

PMID: 37887736 PMC: 10609743. DOI: 10.3390/pathogens12101220.

Hepatitis B virus infection in Indonesia.

Yano Y, Utsumi T, Lusida M, Hayashi Y World J Gastroenterol. 2015; 21(38):10714-20.

PMID: 26478663 PMC: 4600573. DOI: 10.3748/wjg.v21.i38.10714.

The effect of propranolol in malay patients with liver cirrhosis - a pharmacodynamic evaluation.

Zain-Hamid R, Ismail Z, Mahendra Raj S, Shuaib I, Mohsin S Malays J Med Sci. 2013; 10(1):65-73.

PMID: 23365503 PMC: 3557112.

The prevalence of antibody to hepatitis C virus (anti-HCV) in patients with acute and chronic liver diseases in Jakarta, Indonesia.

Sulaiman H, Noer H, Endardjo S, Hoyaranda E Gastroenterol Jpn. 1991; 26 Suppl 3:179-83.

PMID: 1909263 DOI: 10.1007/BF02779294.

References

SUNG J, Sekine T, Lin T, Nishioka K, Mayumi M, Liao Y . Hepatitis-associated antigen in hepatocellular carcinoma in Taiwan. Taiwan Yi Xue Hui Za Zhi. 1972; 71(7):505-8. View

Kubo Y, Okuda K, Musha H, Nakashima T . Detection of hepatocellular carcinoma during a clinical follow-up of chronic liver disease: observations in 31 patients. Gastroenterology. 1978; 74(3):578-82. View

Hadziyannis S, Merikas G, Afroudakis A . Hepatitis-associated antigen in chronic liver disease. Lancet. 1970; 1(7663):100. DOI: 10.1016/s0140-6736(70)92672-3. View

Farrell G, Joshua D, Uren R, Baird P, PERKINS K, Kronenberg H . Androgen-induced hepatoma. Lancet. 1975; 1(7904):430-2. DOI: 10.1016/s0140-6736(75)91494-4. View

SZMUNESS W . Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog Med Virol. 1978; 24:40-69. View

Omata M, Ashcavai M, Liew C, Peters R . Hepatocellular carcinoma in the U.S.A., etiologic considerations. Localization of hepatitis B antigens. Gastroenterology. 1979; 76(2):279-87. View

Kew M, Popper H . Relationship between hepatocellular carcinoma and cirrhosis. Semin Liver Dis. 1984; 4(2):136-46. DOI: 10.1055/s-2008-1040653. View

Trichopoulos D, Tabor E, Gerety R, Xirouchaki E, Sparros L, Munoz N . Hepatitis B and primary hepatocellular carcinoma in a European population. Lancet. 1978; 2(8102):1217-9. DOI: 10.1016/s0140-6736(78)92097-4. View

Chen D, SUNG J, Lai M . Hepatitis Be antigen and antibody in chronic liver diseases and hepatocellular carcinoma. Hepatogastroenterology. 1981; 28(6):288-91. View

10.

Yarrish R, Werner B, Blumberg B . Association of hepatitis B virus infection with hepatocellular carcinoma in American patients. Int J Cancer. 1980; 26(6):711-5. DOI: 10.1002/ijc.2910260603. View

11.

Musca A, Cordova C, Barnaba V, Bonavita M, Levrero M, Zaccari C . HBeAg/anti-HBe system and development of primary hepatocellular carcinoma in patients with HBsAg-positive liver cirrhosis. Hepatogastroenterology. 1983; 30(1):3-5. View

12.

Vogel C, ANTHONY P, Sadikali F, Barker L, Peterson M . Hepatitis-associated antigen and antibody in hepatocellular carcinoma: results of a continuing study. J Natl Cancer Inst. 1972; 48(6):1583-8. View

13.

. Primary liver cancer in Japan. The Liver Cancer Study Group of Japan. Cancer. 1984; 54(8):1747-55. DOI: 10.1002/1097-0142(19841015)54:8<1747::aid-cncr2820540846>3.0.co;2-l. View